66 related articles for article (PubMed ID: 19764991)
1. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia.
Lehrnbecher T; Schubert R; Behl M; Koenig M; Rose MA; Koehl U; Meisel R; Laws HJ
Br J Haematol; 2009 Dec; 147(5):700-5. PubMed ID: 19764991
[TBL] [Abstract][Full Text] [Related]
2. Serotype-specific pneumococcal antibody concentrations in children treated for acute leukaemia.
Patel SR; Bate J; Borrow R; Heath PT
Arch Dis Child; 2012 Jan; 97(1):46-8. PubMed ID: 20705722
[TBL] [Abstract][Full Text] [Related]
3. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
[TBL] [Abstract][Full Text] [Related]
5. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
6. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
Balmer P; Borrow R; Arkwright PD
Vaccine; 2007 Aug; 25(34):6321-5. PubMed ID: 17629373
[TBL] [Abstract][Full Text] [Related]
7. Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules.
Lehrnbecher T; Schubert R; Allwinn R; Dogan K; Koehl U; Grüttner HP
Br J Haematol; 2011 Mar; 152(6):754-7. PubMed ID: 21250973
[TBL] [Abstract][Full Text] [Related]
8. Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia.
Meisel R; Toschke AM; Heiligensetzer C; Dilloo D; Laws HJ; von Kries R
Br J Haematol; 2007 Jun; 137(5):457-60. PubMed ID: 17488489
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment.
Stiehm ER; Roberts RL; Kaplan MS; Corren J; Jaracz E; Rico MJ
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S206-13. PubMed ID: 16021176
[TBL] [Abstract][Full Text] [Related]
10. Post-immunization pneumococcal antibody titers and IgG subclasses.
Sorensen RU; Hidalgo H; Moore C; Leiva LE
Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
[TBL] [Abstract][Full Text] [Related]
11. Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status.
Zhang Q; Bernatoniene J; Bagrade L; Pollard AJ; Mitchell TJ; Paton JC; Finn A
Eur J Immunol; 2006 Jan; 36(1):46-57. PubMed ID: 16342325
[TBL] [Abstract][Full Text] [Related]
12. [The function of the immune system after the treatment of pediatric malignant diseases].
Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of pneumococcal anticapsular antibodies in children with pneumonia associated with Streptococcus pneumonia infection.
Esposito S; Droghetti R; Faelli N; Lastrico A; Tagliabue C; Cesati L; Bianchi C; Principi N
Clin Infect Dis; 2003 Nov; 37(9):1261-4. PubMed ID: 14557973
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
[TBL] [Abstract][Full Text] [Related]
15. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy.
Fioredda F; Plebani A; Hanau G; Haupt R; Giacchino M; Barisone E; Balbo L; Castagnola E
Eur J Haematol; 2005 Jan; 74(1):20-3. PubMed ID: 15613102
[TBL] [Abstract][Full Text] [Related]
16. Immune function risk factors for acute lower respiratory tract infections.
Witt CS; Pomat W
P N G Med J; 1991 Sep; 34(3):211-4. PubMed ID: 1750266
[TBL] [Abstract][Full Text] [Related]
17. [Cytostatic therapy reduces the immune defense. Children treated for leukemia have impaired immunity against measles and rubella].
Nilsson A; Nordin M; De Milito A; Grillner L; Chiodi F; Björk O
Lakartidningen; 2000 Nov; 97(45):5116-8. PubMed ID: 11116890
[TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group.
Ek T; Mellander L; Andersson B; Abrahamsson J
Pediatr Blood Cancer; 2005 May; 44(5):461-8. PubMed ID: 15558707
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P;
Clin Infect Dis; 2009 May; 48(10):1392-401. PubMed ID: 19368505
[TBL] [Abstract][Full Text] [Related]
20. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
